key: cord-0785120-hgbhie7x
authors: Eghbali Zarch, Reyhaneh; Hosseinzadeh, Pegah
title: COVID‐19 from the perspective of dentists: A case report and brief review of more than 170 cases
date: 2021-01-01
journal: Dermatol Ther
DOI: 10.1111/dth.14717
sha: 1f9d0f13208aecf729922de2e2f420584a56bbbf
doc_id: 785120
cord_uid: hgbhie7x

A novel coronavirus which has appeared from China, has been circulating hastily around the world. We summarized the publications including oral manifestation of coronavirus disease 2019 (COVID‐19) cases based on PubMed and Google Scholar data bases, and also present a case that highlights oral lesions 2 days prior to the first COVID‐19 general symptoms. Two authors independently reviewed the papers, 17 studies of more than 170 confirmed cases between ages of 9 and 90 were included. The most common oral manifestation was dry mouth followed by dysgeusia and pseudomembranous fungal structure. Change in tongue sensation and ulceration, muscle pain during mastication, swelling in oral cavity, and herpetic lesions were other common symptoms. Associated symptoms, latency time, treatment, and prognosis have also been meticulously reviewed. We hope that careful clinical intraoral examination on all COVID‐19 positive patients and equally on any patients who need dental care will pave the way for further studies.

A novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that triggers a new infectious respiratory disease, coronavirus disease 2019 (COVID-19) that has appeared from Wuhan, China, has been circulating hastily around the world. It has been declared as pandemic emergency by World Health Organization (WHO), on March 2020. Common clinical features of this virus infection include fever, cough, headache, diarrhea, fatigue, headache, and myalgia. 1 Two new symptoms, anosmia and ageusia, were also found to be widespread, according to the most recent reports. 2 COVID-19 has an incubation time that ranges between 1 and OR (SARS-CoV-2)) AND ((oral) OR (mucocutaneous) OR (manifestation) OR (mucositis))." The time for publication was set to 2019 onwards. Two reviewers independently reviewed the articles. Case reports dealing with oral manifestations of COVID-19 were included.

In addition, the patient of the case we report, provided written consent to publish the characteristics and picture of her case and the identity of the patient has been protected.

A 56-years-old female with underlying health condition of hypertension and chronic sinusitis, reporting history of inverted papilloma lesion in the left maxillary sinus that was partially resected, presented with vesicles on lower lip mucosa. She was examined and followed up via video consultation and asked to send a picture of the lower lip mucosa. History of the oral manifestation revealed 2 days of dry mouth, acute dysgeusia, mild pain, and burning sensation in lower lip mucosa. She reported appearance of two vesicles in the same region and simultaneous systemic symptoms of COVID-19 after 2 days ( Figure 1 ). Our subject systemic symptoms included: high fever, fatigue, and lack of appetite. She did not develop any cutaneous lesion. Polymerase chain reacted (PCR) assay resulted positive for COVID-19, and azithromycin, levofloxacin, montelukast, naproxen, and acetaminophen were immediately prescribed.

The patient reported previous history of herpetic infections.

Although, recurrent HSV infections are less common within the mouth and typically involve the keratinized mucosa, such as gingiva and palate, they can occur on any mucosal site in immunocompromised patients. 4 We proposed herpes PCR testing, however, but due to mild symptoms and financial issues, the patient refused to perform. After 

Overall, 17 studies were included in the final analysis. More than 170 COVID-19 positive Patients developed oral manifestations, ranging from 9 to 90 years of age (Table 1) . All the patients, with the exception of 24, [5] [6] [7] presented with systemic symptoms such as fever, cough, weakness, shortness of breath, diarrhea, and dysgeusia.

The most common oral manifestation was dry mouth, which was reported in 75 of the cases. 71 patients reported changes in taste sensation and a strong association with burning mouth and taste change was found. 3,5,6,8-10 67 patients developed pseudomembranous structure, white plaque or hairy tongue on the intraoral mucosa, with or without other symptoms like dry mouth and glossalgia, 11 of which on the tongue were identified by questionnaire, the etiology remained unknown, while in 55 other cases specimens were taken from the oral mucosa and fungal infection was confirmed, with Candida albicans as the most prevalent strain. 3, 5, 8, [11] [12] [13] 48 patients reported a change in their tongue sensation, 28 of whom suffered from painful ulcers in the area, 15 patients suffered from muscle pain during mastication with a mean VAS score of 3.8, and 10 patients indicated swelling in the oral cavity: four in the palate, four in the tongue, and two in the gums. Change in tongue sensation strongly correlated with swollen palate and plaque-like changes in the tongue. 3, 7, 14, 15 Sporadic reports showed recurrent herpes simplex virus lesions in six cases: four on the hard palate, and two on the tongue. 6, 12, 13, 16 Four patients developed erythema multiforme-like eruptions, three of whom had palatal macules and petechiae and one of whom showed three blisters in the inner lip mucosa. 6, 17 Erosions, erythema, ulcers, necrotizing ulcerative periodontitis, and aphthous like lesions were also observed in single cases. 5, [8] [9] [10] 14, 15, [18] [19] [20] [21] The details on the onset of the oral manifestation was recorded for the 95 of the cases, with a mean of 7.21 days after systemic symptoms, varying from −10 to 42 days. In 42 cases, oral lesions resolved spontaneously or with some basic treatment within 3 weeks, except gingival hyperpigmentation in one patient, detailed information was not documented in other cases.

Several reports and systematic reviews investigated cutaneous lesions due to COVID-19. Sousa et al 22 recently, highlighted the need for further epidemiological research on oral manifestation of COVID-19. As the virus has become a pandemic, there has been continuous production of additional data. We therefore conducted a study to briefly review papers on oral and mucosal symptoms of patients suspected or diagnosed with COVID-19.

The main impact of COVID-19 on oral mucosa seems to be multifactorial, the important role of the immune system is inevitable. Medicine, the nature of the virus and even stress could put the control of the Immune system at risk. A certain state of immune dysregulation may lead to opportunistic infections, drug eruptions, or the risk of exacerbating existing autoimmune conditions via cytokine storm.

Moreover, some researchers assume that oral lesions contributed to COVID-19 are based on the assumption of an Inflammatory response that induces vascular inflammation. 14 A limitation of our research is that we were not able to quantitatively analyze oral manifestations and disease patterns due to vast amounts of unprovided and incomparable data.

In conclusion, our review outlined the clinical characteristics of oral manifestations in patients with COVID-19 and their potential mechanisms. The oral symptoms often appeared after general symptoms such as fever and asthenia, but can still be the initial or only sign of COVID-19. Thus, a careful clinical intraoral examination must be performed on COVID-19 positive patients and equally on any patients who need dental care thoroughly and systematically to ensure that no parts are missing and to obtain further clinical data, which could pave the way for further studies.

The authors declare no conflict of interest. T A B L E 1 (Continued) Author Abbreviations: CGS, common general symptoms (including: fever, cough, headache, diarrhea, or myalgia); NR, not reported.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Is periodontal disease a risk factor for developing severe COVID-19 infection? The potential role of Galectin-3

Olfactory and oral manifestations of COVID-19: sex-related symptomsa potential pathway to early diagnosis

Viral infections of oral cavity

Oral manifestations in a patient with a history of asymptomatic COVID-19: case report

Oral vesiculobullous lesions associated with SARS-CoV-2 infection

Tongue ulcers associated with SARS-CoV-2 infection: a case series

Oral manifestations associated to Covid-19

Oral mucositis in a SARS-CoV-2-infected patient: secondary or truly associated condition? Oral Dis. 2020;1-5

Mucosal involvement in a COVID-19-positive patient: a case report

Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: species identification and antifungal susceptibility pattern

Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?

Oral symptoms and lesions in SARS-CoV-2 positive patient

Oral manifestation of Covid-19 as an inaugural symptom?

Letter to editor: Oral lesions in a patient with Covid-19

Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor

Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings

Oral vesicles and acral erythema: report of a cutaneous manifestation of COVID-19

Oral erosions and petechiae during SARS-CoV-2 infection

Unique skin manifestations of COVID-19: is drug eruption specific to COVID-19?

Necrotizing periodontal disease: Oral manifestation of COVID-19

Considerations on oral manifestations of COVID-19

Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis? Med Hypotheses

COVID-19 from the perspective of dentists: A case report and brief review of more than 170 cases

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

https://orcid.org/0000-0001-7606-8034